Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GW768505A free base is a potent dual inhibitor of VEGFR2 (KDR) and Tie-2 (pIC50: 7.81 for VEGFR2) with anti-angiogenic activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 688.00 | |
50 mg | 6-8 weeks | $ 913.00 | |
100 mg | 6-8 weeks | $ 1,360.00 |
Description | GW768505A free base is a potent dual inhibitor of VEGFR2 (KDR) and Tie-2 (pIC50: 7.81 for VEGFR2) with anti-angiogenic activity. |
In vitro | GW768505A free base acts as an inhibitor of both KDR and TIE2, demonstrating significant inhibition (71–88% inhibition at 100 nM) of tropomyosin-related kinases, including TRKA, TRKB, and TRKC. Furthermore, it exhibits inhibitory effects on the growth of cancer cells in the NCI-60 panel screening. |
Molecular Weight | 537.47 |
Formula | C27H19F4N5O3 |
CAS No. | 501693-25-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GW768505A free base 501693-25-0 Others GW768505A GW-768505A free base inhibitor inhibit